![Kallanthotatthil G. Rajeev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kallanthotatthil G.
Rajeev formerly worked at Alnylam Pharmaceuticals, Inc., as Senior Director-Drug Discovery and Verve Therapeutics, Inc., as Vice President-Chemistry, Manufacturing & Controls from 2018 to 2025.
Dr. Rajeev received his doctorate degree from National Chemical Laboratory.
| Sociétés | Poste | Fin |
|---|---|---|
| VERE THER | Corporate Officer/Principal | 25/07/2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
National Chemical Laboratory
 National Chemical Laboratory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
